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ABSTRACT
Continuous quality improvement projects and appropriate documentation are an
essential component to continue to receive Ryan White grant funding. Compliance with
mandated aspects of quality improvement is an extremely important concept-specifically
for a clinic setting that cares for the largest HIV positive population in the state of
Mississippi. The Health Resources and Services Administration (HRSA) provides
directives mandating that quality improvement projects should be applicable to areas of
need and provide for outcomes that ensure quality care for HIV positive individuals
(2016).
Initially, this clinic’s rate of compliance with the HRSA Cervical Cancer
Screening Performance Measure was subpar to the last reported national average. Due to
the increased incidence of cervical dysplasia within the HIV positive female population,
cervical cancer screening was chosen for improvement focus. The purpose of this Doctor
of Nursing Practice (DNP) project was to increase the number of HIV positive women
referred for cervical cancer screening within the clinic setting. The overall aim of the
project was to increase cervical cancer screening within this vulnerable population.
Literature has indicated that provider-initiated referrals provide for increased
adherence. A visible, provider-initiated algorithm was introduced for a period of three
months. At the end of the project period, pre-and post-intervention referral rates were
compared to determine project success and significance. Comparison of collected data
confirmed a significant difference between pre- and post-intervention referrals.
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CHAPTER I - INTRODUCTION
HIV affects low-income minorities, specifically in the South, at an alarmingly
disproportionate rate (Williams, Moneyham, Kempf, Chamot, & Scarinci, 2015). African
American women have a disproportionately higher prevalence of both HIV infections and
cervical cancer (Williams et al., 2015). Barriers to preventative care such as cervical
cancer screening cited within minority populations are (a) lack of knowledge of
resources, (b) denial, (c) fear, (d) competing obligations, and (e) embarrassment (Nonzee
et al., 2015). Facilitators to care have been identified as (a) identification of an
abnormality, (b) provider-initiated actions, (c) motivation from family and friends, and
(d) patient empowerment through education (Nonzee et al., 2015).
The Ryan White Comprehensive AIDS Resources Emergency Act of 1990,
mandates grant recipients to establish and maintain a clinical quality management
programs ensuring patients provided services with grant funds have access to care that is
consistent with the most recent Health and Human Service (HHS) Guidelines for
treatment of Human Immuno-Deficiency (HIV) and prevention of opportunistic
infections. Continuous quality improvement efforts are focused on areas that reflect the
needs of people living with HIV (Health Resources and Service Administration [HRSA],
2016). Recommendations for clinical quality management programs include utilization
of organized, structured processes to implement strategies to align care with current
guidelines (HRSA, 2016).
Since the introduction of Highly Active Anti-Retroviral Therapy (HAART), the
life expectancy of HIV positive individuals adhering to HAART therapy, closely
resembles that of the HIV negative patient, effectively shifting HIV from a terminal
1

diagnosis to a chronic manageable condition (Cross et al., 2014; Simenson et al., 2014).
Due to the increase in lifespan, more emphasis is now placed on preventive health
measures (Cross et al., 2014; Koethe, Moore, & Wagner, 2008). One such preventative
measure is cervical cancer screening.
Cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC) are
increased within the HIV positive population (Aberg et al., 2014; Brogly et al., 2007;
Denslow, Rositch, Firnhaber, Ting, & Smith, 2014). Women who are HIV positive have
a rate of ICC that is four to five times higher than HIV negative women (Aberg et al.,
2014; Brogly et al. 2007; Denslow et al., 2014). In 1993, due to the link between HIV
and invasive cervical cancer, the Center for Disease Control and Prevention (CDC)
categorized ICC as an Acquired Immuno-Deficiency Syndrome (AIDS) defining illness
(National Institute of Health, 2011).
Despite this increased risk, cervical cancer screening remains suboptimal within
the HIV positive female population (Baranoski, Horsburgh, Cupples, Ashcengrau, &
Stier, 2011; Frazier et al., 2016), only 50-60% of HIV positive females report being
screened at least once in the three-year period (Baranoski et al., 2011; Leece et al., 2010).
Comparatively, the 2010 National Health Interview Survey reported the general female
population cervical cancer screening rate to be 83% (CDC, 2012). HIV positive women
also present for cervical cancer screening, diagnosis, and management at a later stage of
the disease resulting in a negative impact on prognosis (Logan, Khambaty, D’Souza, &
Menezes, 2010).
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Background and Significance
Incidence of high-grade cervical intraepithelial lesions (CIN 2+) have been
documented as having a median three-fold increase in HIV positive females and
progression from a low-grade to a high-grade lesion is also significantly faster (Denslow
et al., 2014). Due to these factors, commencement of cervical cancer screening is
recommended to start within one year of initiating sexual activity but no later than 21
years of age even if the transmission was perinatal (“Panel on Opportunistic Infections,”
2013). Follow up for atypical squamous cells of undetermined significance (ASC-US)
and low-grade squamous intraepithelial lesions (LSIL) found on cervical cytology is also
handled differently, requiring referral and follow-up with colposcopy (“Panel on
Opportunistic Infections,” 2013).
Globally, researchers have reported nearly all cases of cervical cancer and
cervical dysplasia are attributable to infection with the human papilloma virus (HPV)
with presence of the virus detected in 99.7% of cervical cancer cases (Frumovitz, 2017).
Two specific strains of HPV, 16 and 18, are highly oncogenic and together they account
for 70% of cases worldwide (World Health Organization [WHO], 2016). Approximately
80% of sexually active individuals are exposed to HPV within the first two years of
initiating sexual activity.
Compared to HIV negative women who often clear the virus within two to
twenty-fours months after infection, HIV positive women often have HPV infections that
persist (WHO, 2016). Researchers have reported that between 25-44.9% of HIV infected
women with normal cervical cytology were infected with oncogenic strains of HPV
(Cubie, Seagar, Beattie, Monaghan, & Williams, 2000; Musa et al., 2013). On average
3

HPV infections take 5-10 years to progress to cervical cancer in the HIV infected female
population as compared to 15-20 years in HIV negative females (WHO, 2016).
Review of Evidence
A review of the evidence was conducted in two parts. Initial search was focused
on determining the significance of failing to perform recommended cervical cancer
screening. After determination that cervical cancer screening was a significant aspect of
care for the HIV positive female a secondary search was focused on specific barriers to
screening and recommendations that would facilitate adherence to screening and improve
quality of care for HIV positive women.
Databases searched included the Cumulative Index to Nursing and Allied Health
Literature (CINAHL) with full text, Medline, and PubMed. The following key search
terms were initially utilized for significance and background: HIV, HPV, cervical cancer,
screening, incidence, progression, and dysplasia. An initial search limited to full text,
English only with publication dates between 2012 and 2017 yielded 943 articles. After
removal of duplicates 467 articles were available and after narrowing the search to only
women in the United States 57 articles were left for review. Abstracts, titles, and
publication dates were used to determine which articles would receive further review.
After review of evidence related to the significance and background of the
problem, CINAHL with full text, Medline, and PubMed were again searched to include
the following key search terms: HIV, cervical cancer screening, pap smears, preventive
health care, barriers, and facilitators. An initial search limited to full text, English only
with publication dates between 2012 and 2017 yielded 460 articles. After removal of
duplicates 283 articles were available and after narrowing the search to only women in
4

the United States 92 articles were left for review. During this second phase of evidence
review, abstracts, titles, and publication dates were again used as criteria to determine
articles that received further review.
Review of available reference lists revealed another 20 previously published
articles that were included for consideration. In total, there were 23 articles that were
selected for inclusion due to strength and applicability to this quality improvement
project. Articles chosen were related to (a) the increased incidence or prevalence of
cervical dysplasia seen in the HIV positive population, (b) progression of cervical lesions,
(c) identified facilitators and barriers to cervical cancer screening in HIV positive
females, and (d) expert guidelines. A literature matrix is included with information from
each of the chosen articles (see Appendix A).
Cervical Dysplasia
In a systematic global review conducted by Denslow and colleagues (2014), 15
studies met inclusion criteria to evaluate incidence of cervical dysplasia in HIV positive
women; N=5882. The data extrapolated from these studies showed that per 100 lifeyears studied, incidence of any cervical lesion was between 4.9-21.1 cases for HIV
infected females. Incidence of high-grade cervical lesions was between 0.4-8.8 cases per
100 life-years. There was a median three-fold increase of cervical lesions in HIV
positive women when compared to HIV negative women (Denslow et al., 2014, p. 164).
In the same systematic global review conducted by Denslow and colleagues
(2014), 11 studies were reviewed to measure progression of cervical lesions; N=1099.
Data deduced from these studies indicated progression from a low- to high- grade lesion
to range between 1.2-26.2 cases per 100 life-years for HIV positive women. HIV
5

positive women were also found to be twice as likely to have progression of cervical
lesions when compared to HIV negative women (Denslow et al., 2014, p. 169).
Brogly and colleagues (2007) found the prevalence of atypical squamous cells of
undetermined significance (ASC-US) or higher cervical abnormality found on first
screening within the HIV positive, perinatally infected, female population was 29.7%,
N=101. Of the 21 girls who underwent appropriate follow-up, 47.6% of cases either
persisted or progressed to a more invasive lesion despite colposcopy, cryotherapy,
excision, or a combination. Fourteen HIV positive, perinataly infected females did not
undergo intervention and seven cases persisted or progressed to a more invasive lesions
(Brogly et al., 2007).
In a retrospective cohort review of medical records of HIV positive women
receiving care from January 1, 2002 to December 31, 2006 at an HIV clinic located in the
Western United States, 69 women met inclusion criteria for chart review. Of the 69
women, 77.9% had at least one cervical screening during the study period (Rahangdale,
Sarnquist, Yavari, Blumenthal, & Israelski, 2010). The collected cytology yielded 66.9%
normal findings and 33.3% abnormal findings. Abnormalities identified were 50.9%
ASC-US, 36.4% LSIL, 10.9% high-grade intraepithelial lesion (HSIL), and 1.8% atypical
glandular cells of undetermined significance (Rahangdale et al., 2010). Only 62% of
women who had an abnormality identified on cytology had documented follow up within
12 months (Rahangdale et al., 2010).
Barriers to Screening
Factors that have been associated with non-adherence to cervical cancer screening
include (a) being in a racial minority, (b) lacking insurance coverage, and (c) not
6

receiving cervical cancer screening at the same location as primary HIV care (Frazier et
al., 2016). Although lack of insurance coverage has been noted as a barrier to cervical
cancer screening, having private insurance has also demonstrated decreased adherence
rates (Simonsen et al., 2014). A retrospective cohort study of HIV positive women
receiving care at an HIV clinic associated with the University of Utah reported a
statistically significant correlation between having private health insurance coverage and
not having had cervical cancer screening, p=0.025 (Simonsen et al., 2014). Researchers
noted that this correlation could be related to the copay that women with private
insurance are likely required to pay to receive services from an outside clinic (Simonsen
et al., 2014).
Fletcher et al. (2014) found that notable barriers to cervical cancer screening in
HIV positive females are (a) lack of education on the importance of screening, (b) lack of
education that cervical cancer can be prevented with appropriate screening, and (c)
difficulties with scheduling and remembering appointments for gynecological services.
The barriers reported by Fletcher et al. (2014) were derived from interviews conducted as
part of a qualitative focus group of 33 HIV positive females receiving care at a health
center located in Houston, Texas. The women who participated in this study were
predominantly African American, and had a median age of 51 years (Fletcher et al.,
2014).
In a retrospective chart review of 200 randomly selected charts of HIV positive
women receiving care in a health department setting, lack of insurance was found to be a
statistically significant barrier to cervical cancer screening (Logan et al., 2010).
Researchers reported that 64.7% of women who did not receive a pap smear were
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uninsured, p=0.0185 (Logan et al., 2010). The HIV positive women receiving care in this
clinic were also found to be predominantly minorities—57.4% African American and
22.8% Hispanic (Logan et al., 2010). They were also found to be economically
disadvantaged with a mean income of $8,180 annually (Logan et al., 2010).
Andrasik, Rose, Pereira, and Antoni (2008) used Anderson’s Behavioral Model of
Health Services to identify barriers in 35 HIV positive African American women who
had not received cervical cancer screening within the past five years. These researchers
noted primary barriers to be (a) low self-esteem, (b) fear, (c) financial distress, and (d)
lack of transportation. This study also highlighted the impact that psychological barriers
have on HIV positive women when attempting to obtain cervical cancer screening
services (Andrasik et al., 2008).
Another retrospective chart review of 148 HIV positive females receiving care at
a clinic located in New Haven, Connecticut found that cervical cancer screening
adherence rates were lowest among patients being cared for by infectious disease
specialists (Koethe, Moore, & Wagner, 2008). The HIV positive females under the care
of infectious disease specialists were found to have a 47% compliance rate of cervical
cancer screening (Koethe et al., 2008). Comparatively, HIV positive women receiving
HIV primary care from a generalist, not specialized in infectious disease were found to
have a cervical cancer screening rate of 55% (Koethe et al., 2008).
Facilitators to Screening
Nonzee et al. (2015) conducted semi-structured interviews based on the SocialEcological Model integrated with the Theory of Reasoned Action to determine factors
that facilitated cervical and breast cancer screening within low-income, minority women.
8

The participants were elicited from three health care facilities located in Chicago, Illinois.
Adherence to recommended cervical cancer screening within the minority population
studied were facilitated by provider-initiated actions such as: (a) education on importance
of screening, (b) recommendation for appropriate screening intervals, and (c) referrals
(Nonzee et al., 2015).
In a retrospective cohort study conducted by Baronski and Stier (2012), factors
that contributed to appropriate follow-up after abnormal cervical cytology were found to
be (a) higher education level of the patient, (b) high-grade cervical lesion identified, and
(c) abnormality found by a nurse practitioner (NP) performing women’s healthcare
within the same clinic the patient was receiving HIV primary care. Time to follow up for
abnormalities found by the HIV NP were significantly faster when compared to both
infectious disease physicians at the same clinic and providers at the gynecological clinic
(Baronski & Stier, 2012). Decreased time to follow-up is important because lapses of
time greater than 6 months between abnormal findings on the index cytology and followup with colposcopy for histological evaluation have been cited as increasing negative
health outcomes (Baranoski & Stier, 2012).
Fletcher et al., (2014) conducted focus groups using the Health Belief Model to
determine themes associated with adherence to cervical cancer screening in HIV positive
females. Facilitators were found to be: (a) awareness of increased risk of cervical cancer
in HIV positive women, (b) awareness that cervical cancer could be prevented with
appropriate screening, and (c) a trusting relationship with their HIV primary provider.
Recommendations from this study included integration of cervical cancer screening into
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HIV primary care and ensuring education concerning this screening was framed as a
preventative measure (Fletcher et al., 2014).
Education about risk of cervical cancer as well as early detection producing more
positive outcomes provided by the patient’s primary HIV provider have been related to
increased compliance (Cross et al., 2014). Barriers to appropriate cervical cancer
screening for HIV positive women include lack of screening being performed by the
patient’s primary HIV caregiver as well as lack of coordination of HIV and women’s
healthcare at one location (Frazier et al., 2016). Due to the increased compliance of HIV
positive women who receive cervical cancer screening at their primary HIV provider,
integration of women’s health services within this setting is a common theme to increase
cervical cancer screening (Baronski & Stier, 2012; Frazier et al., 2016; Oster, Sullivan &
Blair, 2009).
Synthesis of Evidence
Identification of facilitators and barriers through synthesis of literature was
important to this project. The project structure accounted for specific aspects of barriers
and facilitator within its design. The visual algorithm addressed these barriers by (a)
prompting the provider to make the patient aware of the availability to receive the
cervical cancer screening within the clinic setting, (b) addressing the importance of
cervical cancer screening by educating the patient on the increased risk, (c) addressing
patient fear by educating the patient on the ease of cervical cancer prevention and
treatment with early and appropriate screening, (d) addressing competing obligations by
offering the ability of a same day appointment or scheduling an appointment at the
convenience of the patient, and (e) decreasing embarrassment by having a female NP
10

who is experienced in various aspects of women’s health in vulnerable populations
perform the screening.
A synthesis of the literature showed an elevated risk of cervical dysplasia in HIV
positive women that is significantly increased when compared to HIV negative women
(Brogly, 2007; Denslow et al., 2014; Rahangdale et al., 2010). Barriers to screening are
many and have been cited as stemming from sociocultural factors as well as features that
interfere with the structural and systematic process of referral for cervical cancer
screening. Evidence supports integration of women’s health services within the setting of
HIV primary care (Baronski & Stier, 2012; Frazier et al., 2016; Oster et al., 2009).
Needs Assessment
Researchers have reported suboptimal rates of cervical cancer screening within
the HIV positive population (Williams et al., 2015). Discrepancies have also been noted
between self-report and documented evidence of cervical cancer screening. In a study
conducted by Frazier and colleagues (2016), 78% of HIV positive females self-reported
having a pap smear within the year proceeding the interview; however, researchers could
find documented receipt of cervical cancer screening in only 45% of the respondents.
Lack of appropriate cervical cancer screening has been evidenced both nationally
and at this clinic location. Per data reported from 126 clinics, located in various locations
throughout the United States that receive Ryan White Part C and D funds the mean for
the 2011 reporting year, for the cervical cancer screening measure was 60%, N=2793
(National Quality Center, 2013). This project location had an initial cervical cancer
screening compliance rate of 32%, half of the 2011 reported national average.
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Researchers report that providing women’s health within the same clinical setting
as HIV primary care greatly increases the likelihood of follow-up for preventative health
maintenance, such as cervical cancer screening (Baronski & Stier, 2012; Frazier et al.,
2016; Oster et al., 2009). The staffing matrix of this clinic includes: three full-time nurse
practitioners, one part-time nurse practitioner, and four part-time physicians who provide
HIV care to this population. The full-time providers have a patient load of approximately
450 patients, and the part-time providers have between 50-150 patients. This case load
does not allow for the primary HIV provider to perform cervical cancer screening during
clinic visits.
A chart review of every female who was actively receiving services within the
clinic was performed to evaluate the status of cervical cancer screening. If the patient
had a hysterectomy for non-malignant conditions, records were updated accordingly.
Charts were also reviewed to identify women who may have had cervical cancer
screening at an outside provider, such as a local health department or a private clinic.
If the patient received testing at a site affiliated with the clinic location, the
cytology results would be available within the electronic medical record EPIC; however,
this data does not directly transfer into the federal information system (CAREWare) that
is used to report data to HRSA. To import the patient information, the data was
extrapolated from EPIC and manually entered in to CAREWare. The retrieved data was
then organized into an Excel sheet to be filtered, sorted, and validated.
Following informal discussions with the clinic providers concerning lack of
cervical cancer screening, it was clear that this was not a health service the providers
could integrate in to the clinic schedule. The constraints noted were (a) lack of time, (b)
12

competing priorities concerning patients’ healthcare needs, and (c) forgetting to inquire
about health maintenance history. Value stream mapping was conducted to determine
specific strategies to facilitate cervical cancer screening within the clinic.
Historically, ambulatory referrals were placed within EPIC, for gynecological
services, but only a small percentage of women followed up for these appointments.
Approximately 80% of the clinic’s female patients do not have health insurance and
nearly all (95%) fall within 200% of the federal poverty level. These limited resources
make procurement of the recommended cervical cancer screening unobtainable from a
source outside of this clinic’s setting. Researchers have reported that HIV positive
females face additional barriers such as shame and stigma when attempting to receive
women’s health services from a provider other than their primary HIV provider
(Andrasik et al., 2008; Baranoski, et al., 2011; Bynum et al., 2016; Cross et al., 2014;
Fletcher et al., 2014; Frazier et al., 2016).
Since cervical cancer screening guidelines for HIV positive females are set by the
CDC and monitored by HRSA as a standard of care, cervical cancer screening is
financially supported by grant funding. By increasing referrals to an in-house provider
for cervical cancer screening, the cost can be covered by grant funds for those patients
that qualify, and if abnormalities are found, case managers are available to help the
patient apply for a financial assistance program provided for through the academic
medical center. This financial assistance allows the patient to receive appropriate followup at little to no cost depending on financial need.
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Problem Statement
Cervical dysplasia, the precursor to cervical cancer is seen in 20-40 % of all HIV
infected women and progression to invasive cervical cancer is largely preventable with
appropriate cervical cancer screening (Cross et al., 2014). If cytology results within this
clinic follows the previously documented trajectory, an estimated 111-222 women will
present with cervical dysplasia. Ignoring this important health screening could lead to
higher incidence of invasive cervical cancer. ICC without lymph node involvement
results in radical hysterectomy. Cancer that has metastasized to pelvic or paraaortic
lymph nodes results in a poor prognosis regardless of systemic chemotherapy treatment
(Frumovitz, 2016). Receipt of a cancer diagnosis of any type can decreases quality of life
and drastically impact healthcare costs.
Quality improvement initiatives focused on increasing cervical cancer screening
of the HIV positive female population are integral to improving patient outcomes.
Compliance with guidelines set forth by HHS concerning appropriate care of the HIV
positive female patient will ensure continued program funding and sustainability.
Continued quality improvement measures and program sustainability impact aggregate
population health.
Project Purpose
This project’s goal was to create a systematic process change that would increase
provider-initiated referrals for HIV clinic-based cervical cancer screening. Achievement
of this goal would support the overall aim of increasing the number of HIV positive
women being appropriately screened for cervical cancer. The long-term goal to improve
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population health would be achieved by the impact and sustainability of this quality
improvement intervention.
Theoretical Framework
This project was built around Donabedian’s Structure-Process-Outcomes Quality
Improvement Model. Donabedian’s Quality Improvement Model lays out three
pathways: (a) structure, (b) process, and (c) outcome to evaluate health care (Donabedian,
1980). The structure of health care is constituted by both support provided for quality
care and the environment in which the care is provided (Donabedian, 1982). Appropriate
and available supplies, equipment, proficiency of healthcare personnel as well as barriers
and facilitators to both access and care are all encompassed within structure (Donabedian,
1982). Process includes patient and provider interactions as well as the provider’s
technical proficiency. The process of providing health care that meets evidenced-based
guidelines and practice standards is the measurement of quality of care (Hickey &
Brosnan, 2012). Donabedian (1980) postulated that process was the primary object of
study. The outcome is defined as a measurable change in patient care, effected by both
structure and process (Donabedian, 1982).
DNP Essentials
There are eight essential elements applied to the Doctor of Nursing Practice
(DNP) degree (American Association of Colleges of Nursing, 2006). The development
of this quality improvement project encompasses all eight essentials as follows:
•

Essential I, Scientific Underpinnings for Practice, was achieved by an
extensive review of available evidence encompassing both quantitative
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and qualitative studies. Information was extrapolated and applied to this
quality improvement project.
•

Essential II, Organization and Systems Leadership for Quality
Improvement and Systems Thinking, was achieved by examining the
structure and process within the organization that could be improved upon
to provide for more positive outcomes within the specified population.

•

Essential III, Clinical Scholarship and Analytical Methods for EvidenceBased Practice, was met by extensive literature review and analysis of
available evidence, including expert guidelines, current qualitative and
quantitative studies, and historical research studies to apply to practice
improvement.

•

Essential IV, Information Systems/Technology and Patient Care
Technology, utilized both facility information system-EPIC, as well as
available federal information system-CAREWare.

•

Essential V, Health Care Policy for Advocacy in Health Care, this
essential was met because the results of this quality improvement project
will increase the healthcare outcomes of HIV positive women by
establishing a visible algorithm for providers to increase utilization of
available recommended guidelines for cervical cancer screening.

•

Essential VI, Interprofessional Collaboration for Improving Patient and
Population Health Outcomes, this essential was met by collaboration with
HIV care providers and other members of the healthcare team to establish
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a quality improvement project that would improve the health of a unique
and vulnerable population.
•

Essential VII, Clinical Prevention and Population Health for Improving
the Nation’s Health, met by constructing a quality improvement plan that
could be used in other facilities caring for HIV-positive females that may
be struggling with adherence to appropriate cervical cancer screening.

•

Essential VIII, Advanced Nursing Practice, was met because it provides
for collaboration between various healthcare providers to achieve common
goals; collaboration being an essential element in advanced nursing
practice.
Summary

Chapter one introduced the importance of cervical cancer screening in HIV
positive women. This chapter also highlighted the need to increase cervical cancer
screening within the location chosen for this DNP project. A thorough review of the
evidence was performed to identify facilitators and barriers to cervical cancer screening
that were then used as a framework to build a clinic specific intervention to increase
referrals to an in-house provider.
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CHAPTER II – METHODS
Overview
Rapid cycles of quality improvement are used within this clinic’s quality program
infrastructure. The data extrapolated from these rapid cycles was used to determine the
best theoretical framework for this quality improvement project. Inconsistencies were
found in both the structural and procedural methods of delivering cervical cancer
screening services.
Structure within this quality improvement project pertained to the clinic
environment and providers. The structure received some previous improvement outside
of the scope of this project by integration of cervical cancer screening within the HIV
clinic setting. Process was evidenced by the provision of provider-initiated referrals for
cervical cancer screening. The measured outcome was the number of provider-initiated
referrals.
Setting
The setting for this doctoral project was a large, urban, academic medical center,
infectious disease clinic that receives Ryan White grant funding. There are over 1900
individual HIV positive patients receiving HIV primary care at this location. Over onethird of those patients are female, and roughly 80% of the female population still meet
requirements for cervical cancer screening. The provider mix includes three full-time
NPs, one part-time NP, and four part-time physicians specializing in infectious disease.
Target Population
The target population was HIV positive females receiving primary care at this
clinic, N=749. The demographics of the women were 89.9% African American/Black
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(n=674), economically disadvantaged, 95.1% (n=712) as evidenced by an annual income
≤ 200% of the Federal Poverty Level, primarily uninsured, 80.1% (n=600), and between
the ages of 18 and 60 years old, 90.1% (n=675). Targeted interest was placed on HIV
positive women who still had a biological cervix or had undergone hysterectomy for
malignant conditions, 74.1% (n=555).
Outcomes of Interest and Evaluation Criteria
The project had two targeted outcomes of interest that were measured to evaluate
the impact of the project. The primary goal of the project was to increase the number of
provider-initiated referrals for HIV positive females to receive cervical cancer screening
provided by an in-house resource provider. To evaluate this goal the use of descriptive
statistics was used to compare baseline referral rates for cervical cancer screening for the
three-month period directly preceding the introduction of the intervention to the referral
rate of the three-month period after introduction of the intervention.
The overall aim of the project was to increase the number of HIV positive female
patients, receiving care at this clinic, who also received appropriate cervical cancer
screening. This outcome was measured by the percentage of HIV positive female
patients who received cervical cancer screening. In a previous article by Cross et al.,
(2014), the introduction of a multidisciplinary quality improvement intervention to
increase cervical cancer screening increased the rates of HIV positive females
appropriately screened by 22.3% over a one-year measurement period. The outcomes for
this quality improvement initiative were evaluated at three-months. Comparison to
achieved outcomes from Cross et al. (2014) any increase ≥ 6% would indicate a success
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with this quality improvement project’s overall aim of increasing cervical cancer
screening rates of HIV positive females receiving care at this clinic.
Outcome 1
Outcome one was the primary project goal. The number of HIV positive females,
receiving primary HIV care in a large, urban, academic medical center who received
interdepartmental referrals was measured. Measurement of the referral rate was
compared at baseline and the following three-months after introduction of a visible
algorithm. Project success was determined by an increase in provider initiated cervical
cancer screening referrals when compared to pre-intervention data.
Outcome 2
Outcome two was the project’s overall aim which was to increase the number of
HIV positive females who received appropriate cervical cancer screening. Increased
cervical cancer screening would increase compliance with the HRSA performance
measure. The HRSA cervical cancer screening measure would be calculated by the
number of women receiving cervical cancer screening divided by the number who qualify
for cervical cancer screening.
Contextual Elements
Donabedian (2003) defined the concept of planned reconnaissance as an action
taken to reveal problems and opportunities for improvement. This portion of quality
improvement is completed by routine surveillance by opinion surveys or performance
monitoring. Assessment of quality of care could be divided into three approaches: (a)
structure, (b) process, and (c) outcomes. Interpretations could not be made by any of
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these approaches unless there was an encoded relationship amongst each piece
(Donabedian, 2003).
Definition of several contextual elements are needed for project clarity and are as
follows:
Baseline Referral Rate: Defined as the number of female patients who were provided
cervical cancer screening by an action that was initiated by their HIV provider.
Cervical Cancer Screening Performance Measure: The percentage of women, over the
age of 18, with a biological cervix or a hysterectomy due to malignant conditions, who
have had cervical cancer screening within the past year, divided by the number of
women, over the age of 18 who qualify for screening.
Provider Initiated Referral: Any referral for cervical cancer screening, notated on the
Ryan White Data Tracking Sheet that was then entered into the CAREWare system by a
Case Manager for the three-month period of October 24, 2017-January 23, 2018,
regardless of appointment status.
Same Day Appointment: Any HIV positive female who required cervical cancer
screening and requested a same-day appointment-regardless of referral source.
Design
After receipt of appropriate approvals, providers and staff were notified by e-mail
that the previously discussed process for cervical cancer screening referrals had been
implemented. This communication clarified the purpose of the algorithm and outlined
the steps that providers should take to ensure the referral was handled properly. Specific
steps to handling referrals was important for accurate data tracking to measure project
outcomes.
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The algorithm (see Appendix B) was laminated and placed in every clinic room
directly by the computer where the provider sits to document each patient encounter. The
algorithm outlined criteria that would qualify a patient for referral for cervical cancer
screening and included talking points that the provider could use to introduce the
importance of cervical cancer screening to the patient. Talking points included: (a) HIV
positive females are at an increased risk of cervical dysplasia-including cervical cancer,
(b) cervical cancer is a preventable cancer when appropriate screening is performed, (c)
cervical cancer screening is available within the clinic setting, and (d) cervical cancer
screening is a measure of care provided through grant funding for uninsured patients.
The algorithm included a request that a release of information (ROI) be signed if the
patient self-reported cervical cancer screening at an outside facility. Due to study reports
of discrepancies between self-report and verifiable documentation of cervical cancer
screening, self-report was not considered evidence of screening (Frazier et al., 2016;
Howard, Argarwal, & Lytwyn, 2009).
The algorithm outlined appropriate candidates for cervical cancer screening
referral. Key talking points were also included on the algorithm to help the provider
educate the patient on the importance of cervical cancer screening. Once the patient
agreed to be referred for cervical cancer screening, the provider checked the box on the
Ryan White Data Tracking sheet (see Appendix C) indicating that the patient had been
referred for cervical cancer screening. The Ryan White Data Tracking Sheets with the
cervical cancer screening referral box checked where given to an identified case manager
at the end of each day.
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All case managers at this clinic are qualified to enter referrals into CAREWare
and initiate provider requested referrals. For simplicity and accuracy during this project
one identified case manager was chosen to handle aspects of data entry and appointment
scheduling for cervical cancer screening referrals. This case manager is a registered
nurse who also serves on the Continuous Quality Improvement Committee and is well
versed in use of the CAREWare system and patient care-including referrals.
The case manager entered the referrals each day into CAREWare and routinely
called patients to set up appointments for cervical cancer screening. Same day
appointments were often available, and she also handled scheduling and facilitation of
these appointments. Blinded reports concerning referrals as well as performance measure
reports measuring the percentage of women appropriately screened was provided to the
investigator by the case manager at the end of each measurement month and at project
closure.
Ethical Considerations
Ethical considerations for this project were applicable to both the referring
provider and the patient being referred. The providers were notified of the project and
proposed intervention prior to implementation. All providers had previously agreed to a
process change concerning referrals for cervical cancer screening, and all providers were
made aware that the number of women being referred would be counted and reported for
the purposes of this quality improvement project.
Assurance was provided that the identity of the referring provider would not be
made available to this investigator and there would be no reprisal should they choose not
to comply with the referral guidelines. If the provider chose not to refer based off the
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methods outlined in this quality improvement project, there would also be no negative
effect to the patient. The patient would still be offered and provided cervical cancer
screening; however, the referral would not be included within the final project outcomes.
Ethical consideration was strongly enforced for the patient. The intervention was
set up so that the referral would be entered into CAREWare and appointments set up by
the case manager at the clinic, which is a duty of her position. This researcher received
blinded reports, at the end of each month and at project end with information on total
referrals placed. The report listed the date of referral for each individual patient and
identified patient by an encrypted unique record number (eURN). This eURN is a
number, generated by the CAREWare program, which includes the patient’s initials,
birthday, and elements of the social security number in no decipherable order.
Prior to project approval, the facility Institutional Review Board (IRB) was
contacted to determine the appropriate ethical actions. This investigator was informed
that due to the nature of the project only a Self-Certification Form for Determining
Whether a Proposed Activity is Research Involving Human Subjects was needed (see
Appendix D). Upon completion of the Self-Certification Form the investigator was
instructed to maintain this document with project records.
A letter of support (see Appendix E) was obtained from the project director for
this clinic’s Ryan White Department. Both the Self-Certification Form and the support
letter along with IRB application where sent for review by The University of Southern
Mississippi’s IRB and approval was granted, given Protocol #1710171702 (see Appendix
F). No intervention was instituted until appropriate approvals were received.
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Summary
Chapter two discussed this project’s setting, target population, and outcomes of
interest. The theoretical framework that was chosen to construct this project was also
discussed. Contextual elements needed to successfully conduct this project were
established and defined.
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CHAPTER III - RESULTS
Comparison of means of pre- and post-intervention referral rates showed a
significant increase after project implementation. On average, the provider-initiated
referrals after introduction of the intervention (M=28, SE=2.082) were significantly
higher than provider-initiated referrals measured at baseline (M=8, SE=1.732). The final
percentage of HIV positive women appropriately screened for cervical cancer also saw a
23% increase over a three-month period; which was a fourfold increase of the
improvement noted by Cross et al., (2014). The increase during the three-month period
after project implementation was also significantly higher than the 15% increase noted
during the six-month period prior to introduction of the intervention.
Table 1
Mean Comparison of Referral Rates
Measurement

N

M

SD

Std. Error Mean

Pre-Intervention

3

8

3

1.732

Post-Intervention

3

28

3.606

2.082

Table 2
Data Table: Monthly Provider Initiated Referrals
Month

Provider Initiated Referrals Received

July 22nd -August 23rd
2017
th
August 24 -September 23rd
2017

8
5
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Table 2 (continued).
September 24th -October 23rd
2017
th
October 24 -November 23rd
2017
November 24th-December 23rd
2017

11

December 24th – January 23rd
2017-2018

25

32
27

Figure 1. Timeline of Project Foundation, Implementation, and Evaluation
Summary
Chapter three discussed the results of the project intervention. Data used to
determine project success was provided including the mean of pre- and post-intervention
measurements. Outcomes from previous quality improvement interventions was
introduced for comparison.
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CHAPTER IV – DISCUSSION
Overview
At the initiation of the project, the case manager thought it would be beneficial to
place both release of information (ROI) sheets in each clinic room as well as the quality
manager’s business card. This provided a way for an ROI to be obtained by the provider
without added inconvenience. The ROIs were turned in with the Ryan White Data
Tracking sheet so that previous cytology results could be requested. If the provider
referred the patient for cervical cancer screening, they could choose to provide the patient
with a business card that could then be presented at check-out. For data tracking
purposes, the provider would still check the referral box for cervical cancer screening.
The front desk clerk was informed that if they received the quality manager’s business
card they were to schedule the patient for an appointment for cervical cancer screening.
This process allowed for some patients to self-schedule for an appointment without the
case manager having to handle setting up the appointment.
The algorithm prompted providers to request ROI documents for testing
performed at outside clinics, and it is possible that this action may have provided an
unexpected benefit on the increase of women appropriately screened, as it is appropriate
to count screening performed at an outside clinic given the results have been reviewed
and verified. It is also possible that having a specific provider who has clinic time
devoted to performing cervical cancer screening has a positive impact on the number of
women screened. This fact would correlate with the recommendation from available
literature that women’s health, such as cervical cancer screening, should be incorporated
with primary HIV care (Baronski & Stier, 2012; Frazier et al., 2016; Oster et al., 2009).
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Recommendations
The blinded nature of the data collection greatly reduced this investigator’s ability
to draw some conclusions. Infectious disease specialists have been noted as having the
lowest percentage of performing cervical cancer screening when compared to providers
of other disciplines (Koethe et al., 2008). Comparison of referral rates of the clinic
providers would be a phenomenon of interest to determine if the impact of removing the
time constraint of screening would increase their willingness to discuss the importance of
this screening with patients. Should the data be unblinded later to identify the provider
who initiated the referral, comparisons could be made between referral rates and provider
type.
Recommendations for future investigation would also include retrospective chart
review to determine how many women referred followed up and review of the cervical
cytology outcome. This clinic would be an excellent location to conduct further scholarly
inquiry on the incidence and progression of cervical dysplasia due to the high number of
female, HIV positive patients. For women who were found to have cervical dysplasia
and had appropriate follow-up, data could also be collected to discern the differences
between the cervical cytology and the pathology. One study conducted by Curry, Sage,
Vragovic, and Stier (2012) reported that 90 HIV positive women with minimally
abnormal cervical cytology defined as ASC-US with HPV or LSIL received appropriate
colposcopy and biopsy. Histological diagnosis included CIN2+ for 29 of these women.
Further data concerning the variances in cytological screening when compared to
diagnostic pathology for HIV positive women with cervical dysplasia would have a
positive impact on the health outcomes for this vulnerable population.
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Implications for Future Practice
Implications for future practice that can be extrapolated from this project include
(a) continuing availability of a provider with dedicated time available to perform cervical
cancer screening within the same clinic the patient is receiving HIV, (b) visible prompts
such as the algorithm used in this project could be utilized for other aspects of health care
that need improvement (i.e. mammography, colonoscopy, immunizations), and (c)
education and emphasis should be placed on the importance of the patient-provider
relationship that exists within the HIV care setting. Visual cues such as the intervention
used in this project could increase integration of preventative health maintenance in
similar clinics. An aging HIV positive population and difficulty accessing health care
increase the need to integrate preventative health services within HIV specialty care.
Available literature has provided multiple articles that have statistically examined
unique variables that may impede cervical cancer screening in HIV positive women.
There is also well documented evidence of the negative impact on HIV positive women
who fail to undergo cervical cancer screening. However, there was only one article
(Cross et al., 2014) that addressed quality improvement interventions related to
increasing cervical cancer screening within the HIV positive female cohort. Due to the
importance of this preventative screening, it is vital that more quality improvement
projects be both implemented and disseminated to facilitate structural and procedural
changes within systems that will impact the long-term health outcomes of HIV positive
women.
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Limitations
This project, although effective at this location may not be reproducible in a clinic
setting without a provider with appropriate time to provide cervical cancer screening.
Due to the aspect of the referrals being blinded to the investigator, it is possible that some
women were referred inappropriately for cervical cancer screening. Inappropriate
referrals would include HIV positive females who had a hysterectomy due to nonmalignant purposes or who had already had appropriate screening within the past year.
These women, although referred, would not increase the percentage associated with
cervical cancer screening measure as they either (a) were not included in the denominator
or (b) were already included in the numerator.
Dissemination
Dissemination included discussion of the project’s outcome with both the
investigator’s preceptor and the clinic’s medical director. Results were sent via e-mail to
all clinic staff, along with words of appreciation and gratitude for their conscientious
efforts to refer their patients for this important screening. Project overview and outcomes
were also discussed with HRSA auditors during a recent on-site visit. This quality
project will also be submitted for review for the March 23, 2018 meeting of the
Mississippi Statewide Quality meeting, which is a quality improvement collaborative that
focuses on improving care for HIV positive patients receiving care through Ryan White
grant funded clinics. Plans for future dissemination include submission of a poster
presentation concerning this quality improvement project during the 2018 National Ryan
White Conference on HIV Care and Treatment, scheduled for December 11-14, 2018 in
Washington D.C. This investigator also plans to submit this work to several HIV/AIDS
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specific journals. Project data will be used as the groundwork for further scholarly
inquiry related to this population. Possible inquiry includes a retrospective chart review
of outcome data for concerning incidence of HPV in the presence of normal cervical
cytology in the HIV positive female patient and incidence and progression of cervical
dysplasia specific to this clinic’s population.
Conclusion
In conclusion, this project was successful, and the intervention was found to
produce significant increases in provider-initiated referrals. As previously noted, HIV
affects women, specifically African American women at a disproportionate rate. There is
sufficient evidence that HIV positive women have an increased risk of cervical cancer
and multiple barriers to receiving cervical cancer screening, but there is minimal
literature related to the improvement of cervical cancer screening adherence rates. This
population would likely benefit from continued scholarly inquiry concerning cervical
cancer screening improvement measure, including interventions that facilitate adherence.
Nurses with terminal, clinical degrees such as the Doctor of Nursing Practice are
positioned to facilitate organizational changes that provide for positive impacts for
population health. This quality improvement project has not only changed the referral
process for HIV positive women but was built on a foundation that effectively
transformed the clinic’s structure as evidenced by integration of cervical cancer screening
within the clinic. Changes instituted in both the structure and process allow for continued
positive outcomes and sustainability.
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APPENDIX A – Literature Matrix
Author/Year
Aberg et al.
(2014)

Design/Sample/Setting Findings
Guideline
HIV positive
females have
increased
Expert Opinion
incidence of
abnormal cervical
cytology that is
10-11 times more
common than
HIV negative
females

Recommendations
Cervical cancer
screening should be
performed at
diagnosis and
should continue
through-out the
female’s lifetime.
There is no
recommendation to
stop screening at
age 65 as there is in
HIV negative
women. All
cervical cytology
that returns
abnormal should be
followed-up with
colposcopy and
directed biopsy.
Consideration to
increase screening
intervals to every
three years if the
female is over age
30 and cytology is
normal and HPV
co-testing returns
negative.

Andrasik
Rose
Pereira
Antoni
(2008)

Individual semistructured interviews
using a qualitative
instrument and openended question to
elicit information.
Participants included
African American,
HIV positive, females
ages 18-49 with no
pap in the last 5 years.

Barriers to
screening should be
considered when
caring for
vulnerable
populations.
Primary HIV
providers should
ensure that patients
are well educated
on the
benefits/risks of
undergoing cervical
cancer screening

N=35
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Researchers used
Anderson’s
Behavior Model
of Health Services
as a framework to
identify barriers to
cervical cancer
screening.
Psychological/
emotional barriers
found were selfesteem and fear.

Baranoski
Horsburgh
Cupples
Aschengrau
Stier
(2011)

Retrospective cohort
study of HIV positive
women, ages 18-60,
receiving HIV care at
an urban medical
center located in
Boston, MA between
October 1, 2003 and
March 31, 2008.
Multivariate analysis
with generalized
estimate equations for
correlated data.
N=549

Economic and
financial barriers
were money to
obtain screening
and
transportation.

and should proceed
appropriately.

Risk factors of no
pap in HIV
positive females
receiving HIV
care.

The clinic setting
had a nurse
practitioner
available on
Monday, Tuesday,
and Friday. The
primary HIV
provider could refer
the patients for pap
smears or the
patient could selfrefer.

Subjects (n) only
53% of women
engaged in HIV
care had received
a pap at any point
during study
duration.

Review of
documentation is
more accurate to
verify receipt of
pap smears than
relying on a
patient’s self-report
alone.
In 84 charts of
women with no pap
testing, 40.5% (34)
had no
documentation of
an HIV provider
ever inquiring
about pap.
Documentation of
cervical dysplasia
history was
associated with
decreased odds of
not having a pap.
CD4≤
200cells/mm³
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increased odds of
no pap.
Baranoski
Stier
(2012)

Retrospective cohort
study was obtained by
chart review of HIV +
females receiving pap
smears at their HIV
providers office
Evaluated time to
colposcopy after
identification of an
abnormal pap smear
using univariate and
multivariate Cox
proportional hazard
modeling.

Only 68% (120)
of women who
had abnormal
cervical cytology
followed up by 12
months.

N=177

Brogly et al.
(2007)

Facilitators to
decreased time to
colposcopy were
being married
higher education
HSIL on pap
CD4≥500
NP HIV provider
performing pap vs
gynecological
provider.

Retrospective chart
review of perinatally
infected girls, ages 13
or over, enrolled in
Protocol 219 C, who
were sexually active
and underwent
screening for cervical
cancer
N=101
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This study found
that of the 174
girls known to be
sexually active,
only 101 had
underwent pap
testing. Of the 101
cases reviewed,
30 had abnormal
cytology at
baseline and only
21 of those
females had
appropriate
follow-up.
Despite follow-up
and intervention,
10 cases
progressed to
more advanced
squamous
intraepithelial
lesions.

Identification of
barriers and follow
up colposcopy are
important and
should continue to
be studied. HIV +
females are at an
increased risk of
invasive cervical
cancer.
Delays in follow-up
over 6 months
increase the
likelihood of
adverse events.
HIV + females are
less likely to have
regression of
cervical dysplasia.
This study found
that 29.7% of
perinatally HIV
infected females
(mean age=16.7
years) had
abnormal cervical
cytology on their
initial pap smear.
The
recommendation is
that HIV positive
females should
have regular
cervical cancer
screening within
the first year of
onset of sexual
activity or age 21
regardless of mode
of HIV
transmission.

Researchers
reported that many
abnormalities
persisted despite
interventions such
as cryotherapy,
excision or both.
Bynum et al.
(2016)

Questionnaire based
study of HIV positive
females, 18 years or
older, receiving care at
an AIDS service
organization located in
the South East United
States.

Questionnaire was
designed to
examine sociostructural
determinants of
cervical cancer
screening.

Used descriptive
statistics to determine
sociodemographic
breakdown and
multivariable log
regression to
determine barriers.

64% of
participants did
not have a
personal health
care provider
other than their
HIV provider.

N=145
Barriers noted
were (a) low
access to health
care, (b) no access
to transportation,
and (c)
perceptions of
stigma.

Many women noted
that their HIV
provider was the
only provider that
they received care
from. Due to this
fact it should be
priority to provide
women’s health
services such as
cervical cancer
screening within
the HIV primary
setting.
Factors such as
transportation and
perceptions of
stigma should also
be considered when
determining what
services to provide
within the HIV care
setting. Many
women feel
stigmatized when
seeking care from
health care
providers who are
not aware of their
HIV status and feel
uncomfortable
disclosing.
The HIV provider
and patient
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relationship is
intimate and that
can be utilized to
provide screening
within the HIV
clinic setting.
Cross et al.
(2014)

Retrospective
comparative study of
pre-and postintervention data after
introduction of a
quality improvement
effort to increase
cervical cancer
screening rates.
Statistics use:
Chi-Square
Fisher’s Exact
Wilcoxon Rank-Sums
N=422

Barriers to
cervical cancer
screening
identified were
training,
preparedness,
environment,
equipment,
provider
incentives, patient
factors, and time.
Post-intervention
the clinic saw a
43% increase in
cervical cancer
screening.

A multidisciplinary
approach should be
used to increase
cervical cancer
screening within
the infectious
disease clinic.
The gains can be
sustained by
interventions that
are sustainable and
relevant to the
clinical
environment.
Increasing and
maintaining
cervical cancer
screening rates
should be a priority
for the HIV
provider.
Patient barriers
such as lack of
education on the
importance of
screening for
cervical cancer as
well as provider
specific barriers
should be
considered when
attempting to
increase cervical
cancer screening
rates.
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Cubie
Seagar
Beattie
Monaghan
Williams
(2000)

Prospective
observational cohort
study of HIV positive
women.
N=106

Curry
Sage
Vragovic
Stier
(2012)

Retrospective analysis
of HIV positive
females who had
minimally abnormal
cervical cytology, who
also received
recommended follow
up colposcopy within
a 6-month time. The
phenomenon of
interest was the
number of women
who had CIN2+
confirmed with
histology results after
having cervical
cytology of ASC-US
with HR HPV or
LSIL.
N=146
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23% of HIV
positive women
with normal
cervical cytology
were infected with
high-risk strains
of HPV.

This study looked
at the number of
women who had
normal cervical
cytology were coinfected with high
risk strains of
human papilloma70% of HIV
virus (HPV). HPV
positive women
co-infection
with ASC-US
cervical cytology contributes to the
were infected with largest percentage
of cervical cancers.
high-risk strains
Due to this fact,
of HPV.
HPV co-testing
90% of HIV
should be provided
positive women
when available and
with cervical
appropriate.
dysplasia greater
than ASC-US
were infected with
high-risk strains
of HPV.
HIV positive
females have an
increased rate of
underlying
Cervical IntraEpithelial
Neoplasia (CIN)
stage 2 or higher
after minimally
abnormal cervical
cytology.

This study analyzed
the difference in
HIV positive
women and HIV
negative women
undergoing cervical
biopsy after
identification of a
minimally
abnormal index
pap.

655 HIV positive
women received a
pap during the
study period.

It is not known if
the higher
incidence of highgrade dysplasia in
HIV positive
women was due to
increased
progression from a
low-grade to a

146 (22%) had
ASC-US/LSIL on
index pap.

high-grade lesion;
however, HIV
90 women
underwent follow- positive women
were found to have
up with
a statistically
colposcopy and
significant increase
biopsy.
in CIN2+ that was
29 (32%) had
confirmed with
CIN2+.
histological
samples, p=0.002,
adjusted OR 2.17,
95%CI (1.33-3.62).
Due to this
difference it is of
great importance
that HIV positive
receive
recommended
cervical cancer
screening and
appropriate followup when even
minimally
abnormal cytology
is present.
Denslow
Rositch
Firnhaber
Ting
Smith
(2014)

Systematic review
Incidence:
Included 15 cohort
studies with
observational data
including 5882 HIV
positive women
Progression:
Included 11 cohort
studies with data from
1099 HIV positive
women
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Cervical cancer
caused by
infections with
HPV genotypes
that cause cancer
and HIV are
strongly
associated with
increased
prevalence,
incidence, and
persistence of
HPV infection.
Women with HIV
have an incidence
rate of cervical
abnormality threefold their negative

HIV-positive
females have a
higher incidence of
cervical cancer and
cervical dysplasia
progresses faster in
HIV-positive
females than their
non-infected
counterparts.
It would be
advantageous to
integrate women’s
health with HIV
care.

counterparts and
HIV-positive
women are twice
as likely to have
cervical lesions
that progress in
severity. The use
of ART/HAART
were not shown to
be significantly
linked to
progression.
Fletcher et al.
(2014)

Frazier et al.
(2016)

Qualitative focus
groups

Barriers include
pain and
discomfort of both
pap and follow up
Focus groups guided
procedures, lack
by the Health Belief
of awareness that
Model
cervical cancer is
preventable,
limited
Participants were HIV transportation,
positive females,
and systemic
receiving care at an
issues with
HIV clinic in Houston, scheduling.
TX between August
2012-November 2012 Facilitators
included strong
provider-patient
relationships and
N=33
knowledge of
increased risk for
cervical cancer.

Holistic approaches
to HIV/AIDS care
should include
cancer screening.

Cross-sectional
analysis of weighted
data retrieved from
chart reviews of
women who received
care at specific sites.

Even in women
receiving
appropriate HIV
care cervical cancer
screening was
found to be
suboptimal.

Logistic regression to
compute adjusted
prevalence ratios and
95% CI
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STI and cervical
cancer screening
are suboptimal in
HIV + women.
Factors that affect
screening rates
were age ≥50, not
sexually active, no
OBGYN provider,
low income,
depression, and no
STI testing.

Education to
providers about
patient’s barriers
and facilitators
should be used and
cervical cancer
screening should be
integrated into HIV
care.

Integration of
women’s healthspecifically
cervical cancer
screening and

testing for sexually
transmitted
infections with HIV
care would provide
improved
outcomes.

N=2270

Strategies to
strengthen
engagement of HIV
positive women to
receive cervical
cancer screening
and testing for
sexually
transmitted
infections should
be deployed and
are an important
aspect of providing
health care to HIV
positive women.
Howard
Agarwal
Lytwyn
(2009)

Systematic Review
Meta-Analysis was
used to compare
accuracy of self-report
preventative cancer
screening to medical
record.

Analysis found
that women over
report
preventative
health screening
such as pap
smears and
mammography.

Self-report of
cervical and breast
cancer should be
confirmed by
medical records.

When measuring
frequency of
health
maintenance
measures such as
cervical cancer
screening, lipid
testing, influenza
vaccine
administration and
mammography,

Women with HIV
are found to more
economically
disadvantaged
compared to HIV
positive men and
report greater
obstacles to
obtaining care.

Articles Reviewed
were 37
Koethe
Moore
Wagner
(2008)

Retrospective cohort
study that reviewed
health record of HIV
positive females
receiving care at a
clinic in New Haven,
CT during the years
2001-2002.
N=148
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rates of cervical
cancer screening
are lowest among
infectious disease
specialists (47%
vs 55% for
generalist).

Issuing referrals for
outside providers
for cervical cancer
screening may
decrease the
number of females
who are screened.
Increasing
treatment with
HAART increases
the HIV positive
patient’s life span,
therefore
integration of
health maintenance
resources should be
considered in the
primary HIV care
setting.
There is potential
improvement to
integrate women’s
health into HIV
primary care and
provide a source
for in-house
screening.

Leece et al.
(2010)

Retrospective cohort
study of HIV positive
females engaged in
care at a tertiary care
HIV clinic located in
Ottawa, Ontario
between July 1, 2002
and June 30, 2005
N=218
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Only 58% of
participants had at
least one pap
smear during a 3year period of
care.
33% of the
females who did
undergo cervical
cancer screening
had an abnormal
result

HIV positive
women without a
primary care
provider are less
likely to undergo
cervical cancer
screening.
Given the
definition of a
primary care
provider, for HIV
positive patients the
primary care

provider would
likely be
considered their
primary care
provider.

Logan
Khambaty
D'Souza
Menezes
(2010)

Retrospective Chart
Review
Retrospective random
chart review of 200
women receiving HIV
care at a Florida
Health Department
between January 2000
and May 2006
N= 200

83 % of HIV
positive women
received a pap
smear during the
first year after
diagnosis. Only
24.5% received a
second pap smear
to meet IDSA and
CDC
recommended
screening.
Insurance status
was significantly
related to receipt
of cervical cancer
screening as
64.7% of women
who had not
received a pap
smear had no
insurance
coverage,
p=0.0185.
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HIV positive
patients deserve the
same type of
routine care as their
HIV negative
counterparts,
therefor these
screenings should
be integrated into
HIV care.
Integration of HIV
primary care and
gynecological care
would be beneficial
to increased
adherence of
appropriate
screening.
Continuity and
coordination of
follow-up should
be handled by the
HIV positive
patient’s primary
care provider,
which often by
definition is the
HIV care provider.
There should be a
mechanism in place
to ensure proper
follow up for HIV
positive women
concerning cervical

cancer screening
and follow up.
Musa et al.
(2013)

Cross-Sectional Study
Bivariate and
multivariate logistic
regression

44.9% of women
with normal
cervical cytology
had detectable
high-risk HPV
40/89.

N=89
Although immune
compromised
states have been
noted to decrease
clearance of HR
HPV infections in
HIV positive
women, this study
did not find a
correlation
between HPV
presence and CD4
or viral load.
Nonzee et al.
(2015)

Semi-structured
qualitative interviews
Semi-structured
interviews with
women recruited
receiving follow-up
care for breast or
cervical cancer
diagnosis at federally
qualified health clinics
and health
departments
N=138
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Barriers to
adherence noted
were (a) lack of
knowledge of
resources, (b)
denial or fear, (c)
competing
obligation and (d)
embarrassment.
Facilitators to care
were (a)
abnormality
identification, (b)
patient activation,
(c) providerinitiated activation
and (d) motivation
from family and
friends

Presence of highrisk strains of HPV
should be evaluated
in HIV positive
women even with
normal cervical
cytology.
Recommendations
for further research
to determine if the
presence of HR
HPV in the
presence of normal
cervical cytology is
a predictor of
cervical dysplasia
or cancer over time.

Patient centered
educational
interventions are an
important aspect of
compliance to
follow up in
minority women.
Development of
interventions that
address barriers to
health care for
vulnerable
populations is
critical to provide
effective and
equitable health
care.

Oster
Sullivan
Blair
(2009)

Retrospective
qualitative data review
Data was reviewed of
HIV positive females
interviewed in sites
located in 18 states.
Reasons for not
getting annual pap
smears was reviewed
and logistic regression
was used to draw
conclusions

23% of women
reported not
receiving pap
smears. Chance
of not receiving
appropriate
screening
increased with
age, lower CD4
counts, and not
receiving pap
smear at primary
HIV provider
location.

Education to
providers should be
provided.

HPV 16 alone
accounts for 50%
of cervical
cancers within the
general
population. HPV
18 accounts for
10-15% and all
other high-risk
strains of HPV
account for less
than 5% each.
HPV has an
increased
prevalence in
women prior to
age 30, therefore
routine HPV cotesting should not
be performed in
this age group.
HIV positive
women who are
sexually active
and ages 21 and
younger may have
a higher rate of
progression of

Cervical cancer
screening should be
started within one
year of sexual
activity, regardless
of mode of
transmission and
continue throughout the patient’s
lifetime. HPV cotesting should be
performed at
baseline and
repeated every
three years if both
cervical cytology
and HPV are
negative for women
age 30 or older. If
HPV co-testing is
not performed then
a cervical cytology
should be
performed every
year until the
patient has three
consecutive results
that are normal,

N=2417
Panel on
Opportunistic
Infections in HIVInfected Adults
and Adolescents.
(2013)

Guideline
Expert opinion
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Education to
patients about
screening
recommendations
and importance
should be discussed
with patients.
Integration of HIV
and gynecological
care should be
implemented if
possible to increase
adherence.

Rahangdale
et al.
(2010)

Retrospective cohort
study of medical
records of HIV
positive women
receiving care at a
county-based HIV
clinic in San Mateo,
CA from January 1,
2002-December 31,
2006.
N=69
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abnormal cervical
cytology than
women in older
age groups as well
as HIV negative
females.

then every three
years is adequate.
For women, less
than 30 years of
age cervical
cytology should be
performed
annually, and HPV
testing should only
be ordered as a
reflex for abnormal
results. Follow up
for ASC-US with
positive HPV and
LSIL (regardless of
HPV results)
requires
colposcopy and
appropriate followup. Normal cervical
cytology with HPV
16 or 18 detected
also require referral
for follow-up with
colposcopy.

Out of the women
who met inclusion
criteria (receiving
care for a
continuous period
of 12 months)
77.9% (53)
received at least
one cervical
cancer screening
during the study
period. 59.5%
(47) who had
normal cervical
cytology had a
subsequent
screening within
18 months of the
first. 33.3% (23)
women had one or

Due to increased
incidence of
cervical dysplasia
and cervical cancer
in HIV positive
women, education
and promotion of
cervical cancer
screening should be
vigorously
provided to women
seeking care within
a primary HIV
clinic.
Although women
received some of
the recommended
screening, efforts

Simonsen et al.
(2014)

Retrospective cohort
study of HIV positive
women receiving care
at the University of
Utah’s Infectious
Disease Clinic during
2009
N=192

more abnormal
pap smears. Only
62% of women
who had abnormal
cervical cytology
had follow up
within one year.

should be made to
ensure consistent
appropriate
screening.

Cervical cancer
screening was
documented for
56.8% of HIV
positive women.

Effective patientprovider
communication
improved quality of
care.

HIV negative
women
comparatively
were documented
at 74%.

Patients that
receive care at
Ryan White
Funded clinics
often do not have
access to care
outside of the
clinic. Therefore,
efforts should be
made to provide
preventative health
care, such as
cervical cancer
screening within
the clinic setting.

One-third of the
HIV positive
women had no
health insurance.
Women with
private insurance
are less likely to
receive a pap
smear (p=0.025).
This correlation
could be due to
copay required at
outside clinics.
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Often women with
health insurance
cannot afford copayments for
preventative health
care services at
non-Ryan White
facilities, making
integration
increasingly
important.

Efforts should be
made to incorporate
cancer screenings,
STI testing, and
safe-sex counseling
from both a
provider and a
public health
standpoint.

Williams et al.
(2015).

Qualitative cohort
study

Found multiple
reasons women
did not undergo
cervical cancer
In-depth qualitative
screening such as
interviews based on
(a) lack of
the health belief model knowledge of risk,
and the PEN-3 to
(b) fear of
ascertain why women negative
do or not undergo
diagnosis, or (c)
routine cervical cancer embarrassment.
screening
Factors that
increased
compliance were
N=20
education from
provider and
social support.

48

It was noted that
lack of education
was a significant
theme noted in both
women who had
paps and those who
had not. This fact
makes it possible
that providerinitiated referrals
and suggestions for
cervical cancer
screening can have
a significant
impact.
Development,
implementation,
and evaluation of
health education
interventions
should be culturally
sensitive.
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